[Event Report] The Second Roundtable Discussion “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan” (June 30, 2021)
date : 8/16/2021
Tags: AMR
On June 30, 2021, AMR Alliance Japan held its second roundtable discussion on “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan”
It is estimated that as many as 8,000 people die every year in Japan of AMR-related causes, double the amount of people who die annually from traffic accidents. Globally, AMR leads to the death of up to 700,000 people annually. If trends continue, 10 million people could potentially die of AMR-related causes globally every year by 2050.
Japan’s “National Action Plan on Antimicrobial Resistance (AMR) 2016-2020” (hereafter “AMR Action Plan”) set six goals and numeric targets toward the achievement of the plan. While the numeric targets did help to promote AMR countermeasures, there is concern that they may have in some instances led to excessive disuse of antimicrobials, even in cases where antimicrobial use was appropriate.
The next AMR Action Plan for Japan has not been released as of June 2021. Toward the new plan, this meeting gathered expert opinion on how to set numerical targets for AMR countermeasures from FY2021 onward.
■Overview
Date: Wednesday, June 30, 2021
Format: Online (Zoom Meeting)
Host: AMR Alliance Japan (Secretariat: Health and Global Policy Institute)
■Program
Opening and Explanation of Purpose
Honda Akiko (Member of the House of Councillors)
Presentations
“Human Numerical Targets for the Next Action Plan”
Kazuhiro Tateda (President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
“Animal Numerical Targets for the Next Action Plan”
Tetsuo Asai (Professor, Joint Graduate School of Veterinary Sciences, Gifu University)
Round Table Discussion
Issues Related to Setting Numerical Targets in the Next Action Plan
Moderator:
Tomohito Shibata (Manager, Health and Global Policy Institute)
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)